These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 22403175)
1. Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer. Yang L; Ravindranathan P; Ramanan M; Kapur P; Hammes SR; Hsieh JT; Raj GV Mol Endocrinol; 2012 Apr; 26(4):550-61. PubMed ID: 22403175 [TBL] [Abstract][Full Text] [Related]
2. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530 [TBL] [Abstract][Full Text] [Related]
4. Expression of androgen and estrogen receptors in sertoli cells: studies using the mouse SK11 cell line. Sneddon SF; Walther N; Saunders PT Endocrinology; 2005 Dec; 146(12):5304-12. PubMed ID: 16166216 [TBL] [Abstract][Full Text] [Related]
5. Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells. Maggiolini M; Recchia AG; Carpino A; Vivacqua A; Fasanella G; Rago V; Pezzi V; Briand PA; Picard D; Andò S J Mol Endocrinol; 2004 Jun; 32(3):777-91. PubMed ID: 15171712 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity. Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
8. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2. Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406 [TBL] [Abstract][Full Text] [Related]
9. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Hess-Wilson JK; Webb SL; Daly HK; Leung YK; Boldison J; Comstock CE; Sartor MA; Ho SM; Knudsen KE Environ Health Perspect; 2007 Nov; 115(11):1646-53. PubMed ID: 18007998 [TBL] [Abstract][Full Text] [Related]
10. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196 [TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone administration or G{alpha}q overexpression induces {beta}-catenin/T-Cell factor signaling and growth via increasing association of estrogen receptor-{beta}/Dishevelled2 in androgen-independent prostate cancer cells. Liu X; Arnold JT; Blackman MR Endocrinology; 2010 Apr; 151(4):1428-40. PubMed ID: 20176724 [TBL] [Abstract][Full Text] [Related]
13. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells. Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Shiota M; Yokomizo A; Tada Y; Inokuchi J; Tatsugami K; Kuroiwa K; Uchiumi T; Fujimoto N; Seki N; Naito S Mol Endocrinol; 2010 Jan; 24(1):114-27. PubMed ID: 19884383 [TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046 [TBL] [Abstract][Full Text] [Related]
16. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors. Li N; Chen M; Truong S; Yan C; Buttyan R Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer. Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172 [TBL] [Abstract][Full Text] [Related]